Shanghai Financial Statements From 2010 to 2025
| 601607 Stock | 19.23 0.02 0.10% |
Check Shanghai Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai Pharmaceuticals Valuation or Volatility modules.
Shanghai |
Shanghai Pharmaceuticals Holding Company Current Valuation Analysis
Shanghai Pharmaceuticals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Shanghai Pharmaceuticals Current Valuation | 71.64 B |
Most of Shanghai Pharmaceuticals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shanghai Pharmaceuticals Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Shanghai Pharmaceuticals Holding has a Current Valuation of 71.64 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.
Shanghai Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shanghai Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Shanghai Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shanghai Pharmaceuticals competition to find correlations between indicators driving Shanghai Pharmaceuticals's intrinsic value. More Info.Shanghai Pharmaceuticals Holding is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Shanghai Pharmaceuticals Holding is roughly 2.66 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shanghai Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shanghai Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Shanghai Pharmaceuticals Financial Statements
Shanghai Pharmaceuticals stakeholders use historical fundamental indicators, such as Shanghai Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Shanghai Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Shanghai Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Shanghai Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Shanghai Pharmaceuticals Holding. Please read more on our technical analysis and fundamental analysis pages.
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.